{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:52:38Z","timestamp":1787698358905,"version":"build-2784847793"},"reference-count":50,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Minister of Science and Higher Education","award":["SUBZ.C120.23.042"],"award-info":[{"award-number":["SUBZ.C120.23.042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The major causes of both morbidity and mortality in patients with acromegaly are cardiovascular diseases (CVDs). The polymorphisms of the fat mass and obesity-associated gene (FTO) are associated with obesity, as well as with an increased risk of CVDs. The aim of the study was to determine the relationship of risk alleles of four FTO gene polymorphisms with selected parameters of lipid and glucose metabolism as well as with IGF-1 and GH levels in the group of patients with acromegaly compared to the control group. The study group consisted of 104 patients with acromegaly and 64 healthy subjects constituting the control group. In the whole acromegaly group, the data reveal that the homozygous for risk allele carriers (rs1421085, rs9930506, rs9939609) as well as carriers of only one risk allele have lower IGF-1 concentrations. In the well-controlled acromegaly group, the homozygous for three risk allele carriers of FTO gene polymorphisms have lower HDL cholesterol concentration (rs1121980, rs1421085, rs993609). In the cured acromegaly group, homozygous risk allele carriers rs9930506 tend to have higher levels of total cholesterol and LDL cholesterol. These associations are not observed in the control group. Conclusion: there is an association between FTO gene polymorphisms and the metabolism of lipids, suggesting that the FTO gene may be associated with higher CVD risk in patients with acromegaly. In addition, there is an association between FTO gene polymorphisms and IGF-1, implying that FTO gene may influence\/modify IGF-1 synthesis. Further investigation on a larger scale is required to provide more precise evidence.<\/jats:p>","DOI":"10.3390\/ijms241310974","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T16:06:37Z","timestamp":1688141197000},"page":"10974","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FTO Gene Polymorphisms and Their Roles in Acromegaly"],"prefix":"10.3390","volume":"24","author":[{"given":"Aleksandra","family":"Jawiarczyk-Przyby\u0142owska","sequence":"first","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Kuliczkowska-P\u0142aksej","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kola\u010dkov","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zembska","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-377X","authenticated-orcid":false,"given":"Jowita","family":"Halupczok-\u017by\u0142a","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9546-4593","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Rolla","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Miner","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Ka\u0142u\u017cny","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-6596","authenticated-orcid":false,"given":"Marek","family":"Bolanowski","sequence":"additional","affiliation":[{"name":"Department and Clinic of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wybrze\u017ce Pasteura 4, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.beem.2009.05.010","article-title":"Pituitary tumours: Acromegaly","volume":"23","author":"Chanson","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"642131","DOI":"10.3389\/fendo.2021.642131","article-title":"Complications and Comorbidities of Acromegaly\u2014Retrospective Study in Polish Center","volume":"12","author":"Rolla","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: Review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5603\/EP.a2018.0093","article-title":"Diagnostics and treatment of acromegaly\u2014Updated recommendations of the Polish Society of Endocrinology","volume":"70","author":"Bolanowski","year":"2019","journal-title":"Endokrynol. Pol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-023-03339-1","article-title":"Secondary diabetes mellitus in acromegaly","volume":"81","author":"Moustaki","year":"2023","journal-title":"Endocrine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.20945\/2359-3997000000193","article-title":"Determinants of morbidities and mortality in acromegaly","volume":"63","author":"Kasuki","year":"2019","journal-title":"Arch. Endocrinol. Metabol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: A systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful Mortality Reduction and Control of Comorbidities in Patients with Acromegaly Followed at a Highly Specialized Multidisciplinary Clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/ng2048","article-title":"Variation in FTO contributes to childhood obesity and severe adult obesity","volume":"39","author":"Dina","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Scuteri, A., Sanna, S., Chen, W.-M., Uda, M., Albai, G., Strait, J., Najjar, S., Nagaraja, R., Orr\u00fa, M., and Usala, G. (2007). Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits. PLoS Genet., 3.","DOI":"10.1371\/journal.pgen.0030115"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.1141634","article-title":"A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity","volume":"316","author":"Frayling","year":"2007","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Liu, C., Mou, S., and Pan, C. (2013). The FTO Gene rs9939609 Polymorphism Predicts Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071901"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/bmc-2019-0025","article-title":"The effect of rs9930506 FTO gene polymorphism on obesity risk: A meta-analysis","volume":"10","author":"Doaei","year":"2020","journal-title":"Biomol. Concepts"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Peng, S., Zhu, Y., Xu, F., Ren, X., Li, X., and Lai, M. (2011). FTO gene polymorphisms and obesity risk: A meta-analysis. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-71"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0261-5614(19)32409-4","article-title":"MON-PO576: RS9930506 FTO Gene Polymorphism and Obesity Risk: A Meta-analysis","volume":"38","author":"Doaei","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tig.2010.02.006","article-title":"The genetics of obesity: FTO leads the way","volume":"26","author":"Fawcett","year":"2010","journal-title":"Trends Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11892-014-0486-0","article-title":"FTO and Obesity: Mechanisms of Association","volume":"14","author":"Zhao","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ijo.2010.158","article-title":"The growth hormone\u2014IGF-I axis as a mediator for the association between FTO variants and body mass index: Results of the Study of Health in Pomerania","volume":"35","author":"Rosskopf","year":"2011","journal-title":"Int. J. Obes."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11102-017-0840-8","article-title":"Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly","volume":"21","author":"Franczak","year":"2018","journal-title":"Pituitary"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.118.033794","article-title":"FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair","volume":"139","author":"Mathiyalagan","year":"2019","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.gendis.2020.07.011","article-title":"The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases","volume":"8","author":"Zhang","year":"2021","journal-title":"Genes Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCRESAHA.119.315531","article-title":"Loss of Endothelial FTO Antagonizes Obesity-Induced Metabolic and Vascular Dysfunction","volume":"126","author":"Biwer","year":"2020","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2337\/db07-1466","article-title":"Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI","volume":"57","author":"Freathy","year":"2008","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1467-789X.2012.01025.x","article-title":"The impact of intronic single nucleotide polymorphisms and ethnic diversity for studies on the obesity gene FTO","volume":"13","author":"Jacobsson","year":"2012","journal-title":"Obes. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100832","DOI":"10.1016\/j.mgene.2020.100832","article-title":"Association analysis of FTO gene polymorphisms rs9939609 and obesity risk among the adults: A systematic review and meta-analysis","volume":"27","author":"Ali","year":"2021","journal-title":"Meta Gene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.numecd.2010.01.006","article-title":"Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism\u2013The Finnish Diabetes Prevention Study","volume":"21","author":"Lappalainen","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCGENETICS.108.822320","article-title":"The FTO Gene is Associated with an Atherogenic Lipid Profile and Myocardial Infarction in Patients with Type 2 Diabetes","volume":"2","author":"Doney","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_29","first-page":"145","article-title":"Leptin Receptor Gene Polymorphism may Affect Subclinical Atherosclerosis in Patients with Acromegaly","volume":"8","author":"Turgut","year":"2016","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11102-011-0329-9","article-title":"The growth hormone receptor polymorphism in patients with acromegaly: Relationship to BMI and glucose metabolism","volume":"15","author":"Turgut","year":"2012","journal-title":"Pituitary"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"625981","DOI":"10.1155\/2015\/625981","article-title":"Investigation of the Vitamin D Receptor Polymorphisms in Acromegaly Patients","volume":"2015","author":"Ilhan","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2265.2009.03703.x","article-title":"d3-Growth hormone receptor polymorphism in acromegaly: Effects on metabolic phenotype","volume":"72","author":"Montefusco","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fendo.2019.00643","article-title":"Association of Vitamin D Receptor Polymorphisms with Activity of Acromegaly, Vitamin D Status and Risk of Osteoporotic Fractures in Acromegaly Patients","volume":"10","author":"Gojny","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_34","first-page":"1673","article-title":"The association of ICAM E469K with cardiovascular characteristics of acromegaly","volume":"19","author":"Oguz","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000448844","article-title":"The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis","volume":"105","author":"Franck","year":"2017","journal-title":"Neuroendocrinology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/21623945.2020.1722550","article-title":"Association of FTO rs9939609 polymorphism with serum leptin, insulin, adiponectin, and lipid profile in overweight adults","volume":"9","author":"Mehrdad","year":"2020","journal-title":"Adipocyte"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jc.2015-1917","article-title":"Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment","volume":"100","author":"Mojahed","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"933039","DOI":"10.3389\/fendo.2022.933039","article-title":"The acromegaly lipodystrophy","volume":"13","author":"Freda","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.5603\/EP.a2022.0059","article-title":"Lipid profile abnormalities associated with endocrine disorders","volume":"73","author":"Sokolowski","year":"2022","journal-title":"Endokrynol. Pol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-20-0497","article-title":"Metabolic complications in acromegaly after neurosurgery: A meta-analysis","volume":"183","author":"Cozzolino","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11102-018-0911-5","article-title":"Preclinical markers of atherosclerosis in acromegaly: A systematic review and meta-analysis","volume":"21","author":"Parolin","year":"2018","journal-title":"Pituitary"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gao, X., Shin, Y.-H., Li, M., Wang, F., Tong, Q., and Zhang, P. (2010). The Fat Mass and Obesity Associated Gene FTO Functions in the Brain to Regulate Postnatal Growth in Mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0014005"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/db07-0910","article-title":"Low Physical Activity Accentuates the Effect of the FTO rs9939609 Polymorphism on Body Fat Accumulation","volume":"57","author":"Andreasen","year":"2008","journal-title":"Diabetes"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1038\/oby.2008.408","article-title":"FTO Polymorphisms are Associated with Obesity but Not Diabetes Risk in Postmenopausal Women","volume":"16","author":"Song","year":"2008","journal-title":"Obesity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.metabol.2009.02.019","article-title":"Effect of an FTO polymorphism on fat mass, obesity, and type 2 diabetes mellitus in the French MONICA Study","volume":"58","author":"Legry","year":"2009","journal-title":"Metab. Clin. Exp."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2337\/db10-1340","article-title":"FTO, Type 2 Diabetes, and Weight Gain throughout Adult Life","volume":"60","author":"Hertel","year":"2011","journal-title":"Diabetes"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00125-011-2370-7","article-title":"Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians","volume":"55","author":"Li","year":"2011","journal-title":"Diabetologia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.2337\/db07-1583","article-title":"Implication of Genetic Variants Near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A\/B, IGF2BP2, and FTO in Type 2 Diabetes and Obesity in 6,719 Asians","volume":"57","author":"Ng","year":"2008","journal-title":"Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.gene.2013.06.079","article-title":"Polymorphisms in FTO and near TMEM18 associate with type 2 diabetes and predispose to younger age at diagnosis of diabetes","volume":"527","author":"Kalnina","year":"2013","journal-title":"Gene"},{"key":"ref_50","unstructured":"R Core Team (2021). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: http:\/\/www.R-project.org."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/10974\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:04:20Z","timestamp":1760126660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/10974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":50,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241310974"],"URL":"https:\/\/doi.org\/10.3390\/ijms241310974","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]}}}